Medical Xpress October 10, 2024
Louise Vennells, University of Exeter

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded.

Mounting evidence suggests that hydrogen sulfide plays an important role in the liver. Previous research shows that tiny amounts of hydrogen sulfide in the body regulate how the liver processes fat, but up until recently, there has been no way to do that specifically. It also impacts the function of mitochondria, known as the “powerhouse” of cells, which generate energy.

The new study is led by Jagiellonian University Medical College in Poland and the University of Exeter and published in Pharmacological Research. For the study, mice who were fed a were injected with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article